Can We Learn From Viruses How to Prevent Type 1 Diabetes?
Open Access
- 1 January 2009
- journal article
- review article
- Published by American Diabetes Association in Diabetes
- Vol. 58 (1), 2-11
- https://doi.org/10.2337/db08-9027
Abstract
We will take a journey from basic pathogenetic mechanisms elicited by viral infections that play a role in the development of type 1 diabetes to clinical interventions, where we will discuss novel combination therapies. The role of viral infections in the development of type 1 diabetes is a rather interesting topic because in experimental models viruses appear capable of both accelerating as well as decelerating the immunological processes leading to type 1 diabetes. Consequently, I will discuss some of the underlying mechanisms for each situation and consider methods to investigate the proposed dichotomy for the involvement of viruses in human type 1 diabetes. Prevention of type 1 diabetes by infection supports the so-called “hygiene hypothesis.” Interestingly, viruses invoke mechanisms that need to be exploited by novel combinatorial immune-based interventions, the first one being the elimination of autoaggressive T-cells attacking the β-cells, ultimately leading to their immediate but temporally limited amelioration. The other is the invigoration of regulatory T-cells (Tregs), which can mediate long-term tolerance to β-cell proteins in the pancreatic islets and draining lymph nodes. In combination, these two immune elements have the potential to permanently stop type 1 diabetes. It is my belief that only combination therapies will enable the permanent prevention and curing of type 1 diabetes.Keywords
This publication has 62 references indexed in Scilit:
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008
- Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cellsJCI Insight, 2008
- Cell Therapy for Diabetes Mellitus: An Opportunity for Stem Cells?Cells Tissues Organs, 2008
- Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of DiabetesThe International Journal of Cell Cloning, 2007
- Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patientsProceedings of the National Academy of Sciences of the United States of America, 2007
- Regulatory T‐cell physiology and application to treat autoimmunityImmunological Reviews, 2006
- Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing TregsJCI Insight, 2006
- Microorganisms and autoimmunity: making the barren field fertile?Nature Reviews Microbiology, 2003
- Diabetes Mellitus and Autoimmunity in Patients with the Congenital Rubella SyndromeClinical Infectious Diseases, 1985
- Type I diabetes mellitusDiabetologia, 1978